arimoclomol

19/09/2020 0

arimoclomol Orphazyme Announces FDA Acceptance and Priority Review of New Drug Application for Arimoclomol for Niemann-Pick Disease Type C Copenhagen, Denmark, September 16, 2020 – Orphazyme […]